Salofalk 500mg: Tablets May Show Black Spots Due To The Oxidation Of The Active Ingredient.
SALOFALK 500mg Recall Summary SALOFALK 500mg tablets are being recalled across Canada because some tablets may develop black spots caused by oxidation of the active ingredient. This is a Class I recall, indicating a serious quality issue. The recall affects all SALOFALK 500mg tablets distributed in Canada.
- Product
- SALOFALK 500mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-04-24
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9f3f8a86-1a57-43dd-adb7-5dade2ff505b